Medicare Enrolled
Dr. Dipakkumar Pandya, M.D.
Neurology · Annandale, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pandya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pandya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pandya
Dr. Dipakkumar Pandya is a neurology specialist in Annandale, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pandya performed 7,026 Medicare services across 798 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pandya received a total of $78,778 from 93 pharmaceutical and/or device companies across 1258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pandya is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in NJ
$78,778 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,026
Medicare services
Top 11% in NJ for neurology
798
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~351 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
5,650 | $34 | $145 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
694 | $100 | $239 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
150 | $18 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
78 | $68 | $175 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
77 | $92 | $315 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
76 | $58 | $500 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
63 | $14 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $130 | $376 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
60 | $111 | $366 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
44 | $340 | $928 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $71 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
83.6% high complexity
2.0% medium
14.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$78,778
Total received (2018-2024)
Avg $11,254/year across 7 years
Top 6% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$63,975 (81.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,726 (16.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,077 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,223
2023
$10,817
2022
$13,274
2021
$17,384
2020
$15,502
2019
$4,731
2018
$8,849
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,706
Lilly USA, LLC
$245
Amneal Pharmaceuticals LLC
$220
Teva Pharmaceuticals USA, Inc.
$218
Biogen, Inc.
$170
PFIZER INC.
$168
UCB, Inc.
$160
Lundbeck LLC
$153
Eisai Inc.
$149
Genentech USA, Inc.
$143
ARGENX US, INC.
$135
EMD Serono, Inc.
$108
Kyowa Kirin, Inc.
$72
TG Therapeutics, Inc.
$60
ANI Pharmaceuticals, Inc.
$53
Azurity Pharmaceuticals, Inc.
$50
Neurocrine Biosciences, Inc.
$49
Otsuka America Pharmaceutical, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$47
Celgene Corporation
$44
Novartis Pharmaceuticals Corporation
$39
CSL Behring
$37
Takeda Pharmaceuticals U.S.A., Inc.
$21
Boston Scientific Corporation
$20
SK Life Science, Inc.
$17
AstraZeneca Pharmaceuticals LP
$17
Amylyx Pharmaceuticals, Inc.
$15
Axsome Therapeutics, Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme LLC
$14
JAZZ PHARMACEUTICALS INC.
$13
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 75.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$24,618
AbbVie Inc.
$14,735
Allergan, Inc.
$12,776
Supernus Pharmaceuticals, Inc.
$7,643
Sunovion Pharmaceuticals Inc.
$4,057
Allergan Inc.
$2,115
Biogen, Inc.
$1,296
Novartis Pharmaceuticals Corporation
$1,156
Teva Pharmaceuticals USA, Inc.
$906
UCB, Inc.
$865
Amneal Pharmaceuticals LLC
$618
Lilly USA, LLC
$587
Lundbeck LLC
$413
EMD Serono, Inc.
$402
Eisai Inc.
$335
Alexion Pharmaceuticals, Inc.
$328
PFIZER INC.
$324
Genentech USA, Inc.
$320
Celgene Corporation
$281
CSL Behring
$277
Amgen Inc.
$270
GENZYME CORPORATION
$249
Kyowa Kirin, Inc.
$242
ARGENX US, INC.
$234
Janssen Pharmaceuticals, Inc
$201
Adamas Pharmaceuticals, Inc.
$197
SK Life Science, Inc.
$183
JAZZ PHARMACEUTICALS INC.
$154
ACADIA Pharmaceuticals Inc
$138
EISAI INC.
$133
Biohaven Pharmaceutical Holding Company Ltd.
$118
Acorda Therapeutics, Inc
$115
LivaNova USA, Inc.
$106
ARBOR PHARMACEUTICALS, INC.
$93
Otsuka America Pharmaceutical, Inc.
$93
US WorldMeds, LLC
$87
GE HEALTHCARE
$86
Grifols USA, LLC
$86
Mallinckrodt Enterprises LLC
$84
Amylyx Pharmaceuticals, Inc.
$83
ANI Pharmaceuticals, Inc.
$81
Impax Laboratories, Inc.
$72
Scilex Pharmaceuticals Inc.
$71
Avion Pharmaceuticals
$68
Neurelis, Inc.
$66
Boston Scientific Corporation
$63
Neurocrine Biosciences, Inc.
$62
Akcea Therapeutics, Inc.
$61
TG Therapeutics, Inc.
$60
AQUESTIVE THERAPEUTICS, INC.
$58
Sumitomo Pharma America, Inc.
$56
Avanir Pharmaceuticals, Inc.
$55
IMPEL PHARMACEUTICALS INC.
$52
Azurity Pharmaceuticals, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$48
SCILEX PHARMACEUTICALS INC.
$47
Promius Pharma LLC
$42
TG THERAPEUTICS, INC.
$40
Jazz Pharmaceuticals Inc.
$40
Bausch Health US, LLC
$39
Abbott Laboratories
$38
Philips Electronics North America Corporation
$37
Harmony Biosciences LLC
$37
Greenwich Biosciences, Inc.
$36
Axsome Therapeutics, Inc.
$29
Merz Pharmaceuticals, LLC
$29
Aprecia Pharmaceuticals, LLC
$27
MDD US Operations, LLC
$27
Strongbridge US INC.
$25
Almatica Pharma LLC
$24
Ethicon US, LLC
$24
BOSTON SCIENTIFIC CORPORATION
$21
GE HealthCare
$18
AstraZeneca Pharmaceuticals LP
$17
Exeltis, USA Inc.
$17
Zimmer Biomet Holdings, Inc.
$16
Mallinckrodt LLC
$15
Zogenix Inc.
$15
Octapharma USA, Inc.
$15
Medtronic, Inc.
$15
Assertio Therapeutics, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$15
Alnylam Pharmaceuticals Inc.
$14
Life Molecular Imaging Ltd
$14
Daiichi Sankyo Inc.
$14
Merck Sharp & Dohme LLC
$14
InSightec,Inc
$13
Horizon Therapeutics plc
$13
Bioventus LLC
$12
INSIGHTEC,INC
$12
Biohaven Pharmaceuticals, Inc.
$12
Mallinckrodt Hospital Products Inc.
$11
Aucta Pharmaceuticals, Inc.
$4
Top 3 companies account for 66.2% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BIOPATCH · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · COMIRNATY · COPAXONE · DUOPA · Dhivy · Durolane · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gel One · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · PERCEPT PC BRAINSENSE · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Spritam · Sunosi · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · Turalio · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WELIREG · XADAGO · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in NJ.
Geographic Context
Neurologists within 10 mi
77
Per 100K population
59.5
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
7.5 mi
7.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pandya is a mixed practice specialist, with above-average Medicare volume (top 11% in NJ), with speaking/promotional industry engagement in the top 6% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pandya experienced with immune globulin infusion (octagam)?
Based on Medicare claims data, Dr. Pandya performed 5,650 immune globulin infusion (octagam) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pandya receive payments from pharmaceutical companies?
Yes. Dr. Pandya received a total of $78,778 from 93 companies across 1,258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pandya's costs compare to other neurologists in Annandale?
Dr. Pandya's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pandya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Annandale
Browse neurologists in Annandale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology